The UK’s first dedicated Vaccines Manufacturing Innovation Centre
The world class centre that will give the UK sovereign resilience and a global platform in the fight against Covid and many other diseases besides.
The Vaccines Manufacturing and Innovation Centre, a not-for-profit organisation established...
Zotefoams’ ZOTEK® F foam chosen by InsulFab for safe and effective delivery of COVID-19...
High-performance closed cell, crosslinked fluoropolymer foam helps ensure safe and secure transportation of ultra-cold chain vaccine
As part of the USA’s Operation Warp Speed (OWS) initiative to combat the COVID-19 pandemic, Texas, USA-based InsulFab...
The scientific, political and economic implications of COVID-19: an insider’s perspective
It is widely assumed that the life science industry performed well off the back of the COVID-19 pandemic, with the demand for assays and molecular tools driving unprecedented sales to support global research. This...
UK STRIDES INTO INTERNATIONAL ARENA OF VACCINE DEVELOPMENT
As Oxford University and Imperial College London move into poll position in the race to develop an anti-Covid vaccine, the UK’s first dedicated Vaccines Manufacturing Innovation Centre is preparing to turn their results into...
Call to address lack of patient diversity in research
By Kate Shaw, CEO of Innovative Trials.
Innovative Trials, a clinical trial patient recruitment company, is calling on the medical research community and pharmaceutical sector to come together to tackle the issue of patient diversity in...
BIOQUELL HELPING PHARMACEUTICAL COMPANIES RESUME OPERATIONS POST-COVID-19
Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity
As the world prepares to enter the next phase of the COVID-19 pandemic with the potential...
Euro biotech: breaking down the barriers to a golden age
Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality.
Europe’s tech sector is going from strength to strength....
Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery
University of Birmingham researchers are working to isolate and extract the COVID-19 encounter complex in a form that is stable enough for identification of target sites for future anti-viral drugs.
The encounter complex is formed...
Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms
A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time.
A UCL-led team of international scientists have built on...
UK Government invests £5m to develop ‘library’ of MRNA vaccines
CPI has received a £5 million investment to support the development of an mRNA ‘vaccine library’ as part of the Government’s vaccine support package announced in the Budget by the chancellor, Rishi Sunak.
The vaccine...
Over 1,000 genes linked to severe COVID-19
Researchers from the University of Sheffield and Stanford University in the US have discovered specific genetic signals in people who develop severe coronavirus infection.
Age, body mass index and pre-existing health problems are known to...
Covid-19 transmission chains in the UK traced through time and space with remarkable accuracy...
A team of scientists, led by researchers from the Universities of Oxford and Edinburgh, has analysed the first wave of the Covid-19 outbreak in the UK and produced the most fine-scaled and comprehensive genomic...
How a Novel Drug Discovery Technology Could Help in the Fight Against COVID-19
By Dr Asif Tulah, Alcyomics
Alcyomics has been adapting its service provision and assays to play their part in the race to find new treatments for COVID-19 (SARS-CoV-2) and to better understand how this virus works....
Fishing for answers to the covid conundrum
The eyes of the scientific world have been on a Covid-stricken fishing vessel that seems to have provided the first real evidence outside of a lab that antibodies do indeed protect against reinfection. By...
How NHS Wales streamlined sterile manufacturing to increase CCU capacity for second COVID-19 wave
Connect 2 Cleanrooms (C2C) expedited the design and build of a temporary medicines unit for NHS Wales’ new Central Intravenous Additive Service (CIVAS).
In March during the first COVID-19 surge, the UK Government increased Critical...
COVID-19 TESTING SECTOR DEMAND SET TO CONTINUE AMID VACCINE ROLLOUT
Amid the continued high demand for testing and staggered vaccine rollout, the diagnostics industry, which was valued in 2020 at $17.2bn-$19.8bn, is set to rise further in 2021
The diagnostics sector will continue to see...